Hematologic Diseases

Available as a global test only. Markers tested by flow cytometry include CD19, CD20, CD27, CD38, CD45, CD56, CD117, CD138, cKappa, and cLambda.

disease state indication(s)
Multiple myeloma (MM)

clinical use
The Myeloma MRD Profile by flow cytometry evaluates for the presence of minimal residual disease (MRD) in patients with previously diagnosed and treated multiple myeloma. The limit of detection is 0.01%.

methodology/product platform
Flow cytometry

specimen type and requirements
Bone marrow: 2-3 mL in sodium heparin (green-top) tube.
Note: Use refrigerated cold pack for transport. Make sure cold pack is not in direct contact with specimen.
DO NOT FREEZE. Transport to lab ASAP.

turnaround time
Global (TC & PC): 24-48 hours

cpt code(s)
88184 (x1)
88185 (x9)
88188 (x1)

medicare moldx cpt code
Not applicable

regulatory classification
Laboratory developed test (LDT)

ordering option
Global (TC & PC)